[New York, 25 July 2025] – The global bifurcation lesions market is forecast to grow from USD 1.63 billion in 2024 to USD 2.88 billion by 2031, at a CAGR of 8.3%, according to Clearview Market Insights (CVMI). Growth is driven by the increasing complexity of coronary artery disease, rising multi-vessel cases, and a shift towards imaging-guided and two-stent procedural strategies.

Request Sample: https://clearviewmarketinsights.com/report-details/global-bifurcation-lesions-market/

“Bifurcation interventions are no longer fringe procedures—they are central to modern PCI,” said Dr. Lina Patel, Interventional Cardiology Lead at CVMI. “Technological breakthroughs are expanding what’s treatable while improving safety and precision.”

Abbott, Medtronic, and Boston Scientific lead the market with innovations in stent design and lesion imaging. Advances such as Xience Skypoint and Synergy DES enable improved side branch access and customized stenting solutions.

North America and Europe lead in procedural volume and clinical expertise, while Asia-Pacific is gaining momentum with new cath labs and increasing patient demand. Collaborative training platforms, simulation models, and AI-enhanced PCI planning are making advanced techniques more accessible worldwide.

Ongoing validation of hybrid approaches and dual-stent techniques in global clinical trials is also enhancing procedural confidence, supporting further market penetration through 2031.

For more insights, visit https://clearviewmarketinsights.com/

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369